S

Syndesi Therapeutics

10 employees

Syndesi Therapeutics develops a drug candidate for the treatment of consecutive cognitive disorders of various neurological conditions.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Care
Pharmaceutical

Date founded

2018

Funding rounds raised

Total raised

$21M

from 10 investors over 10 rounds

S

Syndesi Therapeutics raised $7M on September 28, 2020

Investors: SRIW, -, UCB Ventures, Vives Louvain Technology Fund, Novo Holdings and V-Bio Ventures

S

Syndesi Therapeutics raised $21M on February 15, 2018

Investors: SRIW, -, V-Bio Ventures and Vives Louvain Technology Fund

FAQ